Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients

Medical Microbiology and Immunology

Volumn 192, Issue 2, 2003, Pages 61-69

  Lee, Ji Sook ^a   Song, Chang Hwa ^a   Kim, Chul Hee ^b   Kong, Suck Jun ^b   Shon, Mal Hyun ^b   Suhr, Ji Won ^c   Jung, Sung Soo ^a   Lim, Jae Hyun ^a   Kim, Hwa Jung ^a   Park, Jeong Kyu ^a   Paik, Tae Hyun ^d   Jo, Eun Kyeong ^a  

^a Chungnam National University   (South Korea)

^b National Mokpo Tuberculosis Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Konyang University   (South Korea)

Author keywords

Interferon ; Interleukin 10; Interleukin 12; Recurrent pulmonary tuberculosis; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUBERCULIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; RECURRENT DISEASE; SOUTH KOREA; TREATMENT FAILURE; TUBERCULIN TEST;

EID: 0038131039     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-002-0117-2     Document Type: Article

References (44)

1. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1435
2. Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, Drysdale P, Scheel-Toellner D, Girdlestone J, Darbyshire P, Wadhwa M, Dockrell H, Salmon M, Fischer A, Durandy A, Casanova JL, Kumararatne DS (1998) Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 102:2035-2040
3. Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549-1555
4. Cadranel J, Philippe C, Perez J, Milleron B, Akoun G, Ardaillou R, Baud L (1990) In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients. Clin Exp Immunol 81:319-324
5. Chan J, Kaufmann SHE (1994) Immune mechanisms of protection. In: Bloom BR (ed) Tuberculosis: pathogenesis, protection and control. Am Soc Microbiol, Washington DC, pp 389-415
6. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243-2247
7. Cooper AM, Magram J, Ferrante J, Orme IM (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186:39-45
8. De Jong R, Altare F, Haagen IA, Elferink DG, Boer T, Breda Vriesman PJ van, Kabel PJ, Draaisma JM, Dissel JT van, Kroon FP, Casanova JL, Ottenhoff TH (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438
9. Denis M (1991) Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J Leukoc Biol 50:495-501
10. Dlugovitzky D, Bay ML, Rateni L, Fiorenza G, Vietti L, Farroni MA, Bottasso OA (2000) Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol 122:343-349
11. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. JAMA 282:677-686
12. Ellner JJ (1997) Regulation of the human immune response during tuberculosis. J Lab Clin Med 130:469-475
13. El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL (2001) A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis 32:623-632
14. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW (2000) Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 356:1470-1474
15. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572
16. Garcia I, Miyazaki Y, Marchal G, Lesslauer W, Vassalli P (1997) High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-γ in the differentiation of protective granulomas. Eur J Immunol 27:3182-3190
17. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ (1996) Cross-modulation by transforming growth factor-β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon-γ production. Proc Natl Acad Sci USA 93:3193-3198
18. Hirsch CS, Toossi Z, Vanham G, Johnson JL, Peters P, Okwera A, Mugerwa R, Mugyenyi P, Ellner JJ (1999) Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 179:945-953
19. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic' S (2000) Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 97:13853-13858
20. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondaneche MC, Tuerlinckx D, Blanche S, Emile JF, Gaillard JL, Schreiber R, Levin M, Fischer A, Hivroz C, Casanova JL (1997) Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100:2658-2664
21. Kamath AT, Feng CG, MacDonald M, Briscoe H, Britton WJ (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67:1702-1707
22. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-1104
23. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P (1989) The inducing role of TNF in the development of bactericidal granulomas during BCG infection. Cell 56:731-740
24. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH (1997) Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65:4843-4849
25. Li L, Elliott JF, Mosmann TR (1994) IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 153:3967-3978
26. Lim JH, Park JK, Jo EK, Song CH, Min D, Song YJ, Kim HJ (1999) Purification and immunoreactivity of three components from the 30/32-kilodalton antigen 85 complex in Mycobacterium tuberculosis. Infect Immun 67:6187-6190
27. Marchant A, Amedei A, Azzurri A, Vekemans J, Benagiano M, Tamburini C, Lienhardt C, Corrah T, McAdam KP, Romagnani S, D'Elios MM, Del Prete G (2001) Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol 24:187-194
28. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Tsai MM, Flynn JL, Chan J (2001) Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847-1855
29. Munk ME, Mayer P, Anding P, Feldmann K, Kaufmann SH (1996) Increased numbers of IL-12 producing cells in human tuberculosis. Infect Immun 64:1078-1080
30. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M (1996) A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335:1941-1949
31. North RJ (1998) Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113:55-58
32. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, Lin L (1992) IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148:808-814
33. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF (1994) Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 62:5673-5678
34. Saunders BM, Cooper AM (2000) Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78:334-341
35. Smith D, Hansch H, Bancroft G, Ehlers S (1997) T-cell-independent granuloma formation in response to M. avium: role of TNF-alpha and IFN-gamma. Immunology 92:413-421
36. Song CH, Kim HJ, Park JK, Lim JH, Kim UO, Kim JS, Paik TH, Kim KJ, Suhr JW, Jo EK (2000) Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 68:4477-4484
37. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P (2001) HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358:1687-1693
38. Stead WW (1967) Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 95:729-745
39. Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, Wu CY, Seder RA (2000) The role of antigen and IL-12 sustaining Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci USA 97:8427-8432
40. Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S (1990) Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun 58:3286-3292
41. Torres M, Herrera T, Villareal H, Rich EA, Sada E (1998) Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 66:176-180
42. Zhang M, Gately MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF (1994) Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 93:1733-1739
43. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF (1995) T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63:3231-3234
44. Zhang M, Gong J, Presky DH, Xue W, Barnes PF (1999) Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 162:2441-2447